ResMed (RMD) Posts Q1 EPS of $0.36, Tops by 4c

October 28, 2010 4:24 PM EDT
ResMed (NYSE: RMD) reports Q1 EPS of $0.36, 4 cents better than the analyst estimate of $0.32. Revenue for the quarter was $282.0 million, which compares to the estimate of $280.65 million.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment